OEC Trademark

Trademark Overview


On Thursday, May 13, 2021, a trademark application was filed for OEC with the United States Patent and Trademark Office. The USPTO has given the OEC trademark a serial number of 90708918. The federal status of this trademark filing is REGISTERED as of Tuesday, December 13, 2022. This trademark is owned by Omega Therapeutics, Inc.. The OEC trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids
oec

General Information


Serial Number90708918
Word MarkOEC
Filing DateThursday, May 13, 2021
Status700 - REGISTERED
Status DateTuesday, December 13, 2022
Registration Number6926111
Registration DateTuesday, December 13, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 25, 2022

Trademark Statements


Goods and ServicesPharmaceutical agents affecting DNA structure by targeting DNA structure to treat various diseases in the nature of monogenic diseases, cancer, infectious disease, immune disease, hematological conditions, haploinsufficiencies, hepatic disease, channelopathies, endocrine disease, cardiovascular disease, reproductive disease, renal disease, skeletal muscle disease, bone disease, none of the foregoing including omega fatty acids

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 12, 2021
Primary Code005
First Use Anywhere DateSunday, July 31, 2022
First Use In Commerce DateSunday, July 31, 2022

Trademark Owner History


Party NameOmega Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCAMBRIDGE, MA 02141

Party NameOmega Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Party NameOmega Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02140

Trademark Events


Event DateEvent Description
Thursday, June 1, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 1, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 1, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 1, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 1, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 13, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, December 13, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, November 5, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, November 4, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, October 6, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 22, 2022USE AMENDMENT FILED
Wednesday, October 5, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, September 22, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, March 22, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 25, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 5, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, December 20, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 13, 2021ASSIGNED TO EXAMINER
Thursday, August 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 17, 2021NEW APPLICATION ENTERED